- KEI page on Research and Development Cost Transparency Legislation
- EB142: KEI statement on Addressing the global shortage of, and access to, medicines and vaccines, January 24th, 2018
- Expert Panel charts a road map for WHO’s engagement on transparency and R&D, January 15th, 2018
- Asia Pacific Group asks WIPO to initiate exploratory discussions on the Report of the UN High Level Panel on Access to Medicines, December 11th, 2017
- KEI Comments on the Draft Concept Note Concerning the WHO General Programme of Work, October 13, 2017
- KEI comments at July 25, 2017 civil society stakeholder forum at the 19th round of the RCEP negotiation, July 26th, 2017
- SCP26 – Agreement reached on future work reached at WIPO Standing Committee on the Law of Patents, July 6th, 2017
- SCP26: Statement of Knowledge Ecology International on Patents and Health, July 4th, 2017
- HRC35: Human Rights Council adopts Right to Health Resolution, June 22nd, 2017
- WHA70: Statement of Portugal on the Global shortage of, and access to medicines and vaccines, May 28th, 2017
- WHA70 – Side Event on Addressing Access Barriers and Affordability Challenges for Cancer Drugs, May 21st, 2017
- Senate Finance Committee grills Robert Lighthizer (USTR nominee) on trade and IPR policies, March 20th, 2017
- Statement of the European Union – HRC 34 – Panel on Access to Medicines, March 9th, 2017
- Statement of Portugal – HRC 34 – Panel on Access to Medicines, March 9th, 2017
- Notes on 2017 Special 301 Submissions, March 7th, 2017
- Human Rights Council’s Access to Medicines panel set to discuss Report of UN HLP, March 4th, 2017
- Ambassador Shameem Ahsan (Bangladesh) remarks on UN HLP – Opportunities to Advance Health Technology and Access, March 2nd, 2017
- WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines, March 3rd, 2017
- WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines, March 3rd, 2017
- CDC FOIA shows US, WHO opposed request to discuss UNSG’s High-Level Panel on Access to Medicines Report at EB, March 1st, 2017
- MEP Lola Sánchez questions the European Commission: EU’s position on the UN High-Level Panel on Access to Medicines at WIPO, February 22nd, 2017
- WTO Trade Policy Review: Members question the United States on compulsory licensing, Bayh-Dole, UNHLP & Section 337, February 7th,
2017 - Chilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents, January 25th, 2017
- EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines, January 23rd, 2017
- SCP25: Closing Statement of the Republic of South Africa, December 21st, 2016
- PCB39: Address of Justice Michael Kirby – HIV/AIDS & Solidarity – 30 Years On, December 14th, 2016
- SCP27: South Africa urges WIPO to invite UNHLP Co-Chairs to present their findings, December 13, 2016
- PCB39: Eight hour drafting session charts future course for UNAIDS work program on Intellectual Property and the UN HLP, December 9th, 2016
- UNAIDS PCB 39: Statement of India on the Executive Director’s Report to the 39th PCB, December 7th, 2016
- PCB39: Statement of Knowledge Ecology International on Agenda item 6: UNAIDS synthesis report on IP, December 7th, 2016
- WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines, November 16th, 2016
- WTO TRIPS Council – EU’s intervention on the Report of the UN High-Level Panel on Access to Medicines, November 11th, 2016
- WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines, November 10th, 2016
- WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines, November 10th, 2016
- WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines, November 10th, 2016
- WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines, November 10th, 2016
- WTO TRIPS Council – Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines,
October 31st, 2016 - USTR Ambassador Michael Froman’s reflections on the United Nations High-Level Panel on Access to Medicines, October 17th, 2016
- WIPO General Assembly 2016: Opening Statement of Knowledge Ecology International, October 4th, 2016
- KEI Statement on United Nations Secretary-General’s High-Level Panel on Access to Medicines Report, September 14th, 2016
- Summary of Report of United Nations Secretary-General’s High-Level Panel on Access to Medicines, September 14th, 2016
- SCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents, July 7th, 2016
- Human Rights Council adopts watershed resolution on Access to Medicines, July 1st, 2016
- SCP 24 – A fruitful discussion?, June 30th, 2016
- SCP24: African Group submits revised proposal for a WIPO work program on Patents and Health, June 29th, 2016
- Human Rights Council heats up during informal talks on the primacy of human rights over international trade and IP regimes, June 18th, 2016
- WHA69: Resolution WHA69.23 on CEWG follow-up charts course for WHO’s work on R&D, May 28th, 2016
- WHO at the crossroads: negotiations to fund global R&D mired in eight pages of [bracketed] text, May 21st, 2016
- April 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents, May 12th, 2016
- WHO releases program of work and progress report in advance of Consultative Expert Working Group on R&D, April 25, 2016
- CDIP 17: Asia Pacific and African Group raise concerns re: WIPO’s position on the UN High-Level Panel on Access to Medicines, April 11th, 2016
- BIO, PhRMA and US Chamber of Commerce express fear of UN High-Level Panel on Access to Medicines in letter to Senator Hatch, March 31st, 2016
- TRIPS Council March 2016: India reiterates support for de-linkage and references UN High Level Panel on Access to Medicines, March 7th, 2016
- 5 groups express concerns over WIPO statements relating to UN High-Level Panel on Access to Medicines, March 4th, 2016
- KEI submissions to the UN Secretary General’s High Level Panel on Access to Medicines, February 28th, 2016
- SAVE THE DATE – 26 January 2016: Implications of the TPP and RCEP on Universal Health Coverage, January 20th, 2016